{"product_id":"9783319264639","title":"SpringerBriefs in Psychology: How Changing the Model Can Uncover New, More Effective Molecules","description":"\u003ch1\u003eSpringerBriefs in Psychology: How Changing the Model Can Uncover New, More Effective Molecules\u003c\/h1\u003e \u003ch2\u003eKatz, Martin M.\u003c\/h2\u003e \u003cp\u003e\u003c\/p\u003e\u003cp\u003eThis brief guide takes current clinical trial protocols to\ntask and replaces them with a contemporary framework for improving\nnext-generation antidepressants and their underlying science. Innovative models\nare based on a nuanced, neurologically-informed understanding of drug\nmechanisms and the component cognitive, mood, and behavioral aspects of\ndepression. The book reconceptualizes not only the clinical trial process but\nthe clinical concept of depression itself as essential to bringing\npharmaceutical research and development up to date, boosting efficiency and\neffectiveness, finding new molecules, and reducing waste. Case studies and a\nreview of salient depression scales illustrate the potential benefits of such\nwide-scale change. \u003c\/p\u003e\u003cp\u003eIncluded in the coverage: \u003c\/p\u003e\u003cul\u003e\n Why\n     now the need for a new clinical trials model for antidepressants? \n \u003cli\u003eAims\n     and basic requirements of clinical trials: conventional and\n     component-specific models.\u003c\/li\u003e\n \u003cli\u003eMethods\n     for measuring the components and the profile of drug actions: the\n     multivantaged approach.\u003c\/li\u003e\n \u003cli\u003eAchieving\n     the ideal clinical trial: an example of the merged componential and\n     established models.\u003c\/li\u003e\n \u003cli\u003ePrediction\n     and shortening the clinical trial.\u003c\/li\u003e\n \u003cli\u003eThe\n     video clinical trial. \u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\n\n\n\n\n\n\n\n\n\n\n\n\u003c\/p\u003e\u003cp\u003e\u003ci\u003eClinical Trials of\nAntidepressants\u003c\/i\u003e will interest a varied audience, including clinical\ninvestigators, academic and pharmaceutical company scientists, clinical trial\norganizations, psychiatrists, outpatient physicians, psychotherapists, clinical\npsychologists, psychology graduate students, medical students, and government\nagencies such as the FDA.\u003c\/p\u003e\u003cp\u003e\u003c\/p\u003e \u003ch3\u003eDetails\u003c\/h3\u003e \u003cp\u003ePublished by: Springer\u003c\/p\u003e \u003cp\u003ePublication Date: 2016-02-16\u003c\/p\u003e \u003cp\u003eFormat: Paperback\u003c\/p\u003e \u003cp\u003eISBN-13: 9783319264639\u003c\/p\u003e \u003cp\u003eDOI: 10.1007\/978-3-319-26464-6\u003c\/p\u003e \u003cp\u003eDimensions: 235cm x155cm\u003c\/p\u003e \u003cp\u003ePages: 66\u003c\/p\u003e ","brand":"Springer International Publishing","offers":[{"title":"Default Title","offer_id":46610017779852,"sku":"9783319264639","price":49.49,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9783319264639.jpg?v=1773281119","url":"https:\/\/fh90cf-fv.myshopify.com\/products\/9783319264639","provider":"Late Knight Books and Services, LLC","version":"1.0","type":"link"}